Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some ...Learn More


Fluralaner is a systemic insecticide and acaricide that can be administered orally or topically. Bravecto is the trade name. The U.S. Food and Drug Administration (FDA) approved it for flea treatment in dogs under the trade name Bravecto in May 2014 and for topical treatment in ...Learn More


Antibody-drug conjugates (ADCs) usually consist of monoclonal antibodies (mAbs) covalently linked to cytotoxic drugs via chemical linkers. With high specific targeting ability and strong killing effect, it has achieved precise and efficient removal of cancer cells, and has become ...Learn More


Currently, ADC has played a significant role in the treatment of some malignant tumors, such as trastuzumab in the treatment of breast cancer, but its application in the treatment of prostate cancer (PCa) progress slowly. In recent years, ADC has made rapid progress in the ...Learn More


Cell staining is a technique used in microscopy to visualize and differentiate structures within cells. It involves the use of dyes or stains to selectively color specific parts of cells or tissues, allowing researchers to study the structure and function of cells in greater ...Learn More


Cloud Scientists
Popular Plasmids

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2022 MolecularCloud